Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

News Daily News

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

Michael O'Riordan

November 18, 2020

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Daily News

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Caitlin E. Cox

November 17, 2020

News Daily News

PCI at Ambulatory Centers: More Bleeding but No Penalty in Overall Outcomes

Caitlin E. Cox

November 11, 2020

News Conference News AHA 2020

AHA Calls Out Structural Racism as Driver of CVD Inequalities

Shelley Wood

November 10, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Daily News

Young Women With AMICS: High Risk, Inadequate Care

L.A. McKeown

September 29, 2020

News Daily News

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

L.A. McKeown

August 17, 2020

News Daily News

Smartphones and Watches Unlikely to Interfere With Implanted CV Devices

Yael L. Maxwell

August 05, 2020

News Conference News SCCT 2020

For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change

Yael L. Maxwell

July 28, 2020

News Daily News

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

L.A. McKeown

July 17, 2020

News Conference News ISC 2020

Industry Payments to Vascular Neurologists Jump in the Thrombectomy Era

Todd Neale

February 29, 2020

News Daily News

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

Yael L. Maxwell

February 18, 2020

News Conference News STS 2020

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

Yael L. Maxwell

January 29, 2020

News Daily News

Community Death Rates Following Type 2 MI Speak to Lack of Treatments, Trials

Yael L. Maxwell

January 10, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

Advertisement

Funding the Future: How Industry Support for CV Trials Could Evolve

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

PCI at Ambulatory Centers: More Bleeding but No Penalty in Overall Outcomes

AHA Calls Out Structural Racism as Driver of CVD Inequalities

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Young Women With AMICS: High Risk, Inadequate Care

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

Smartphones and Watches Unlikely to Interfere With Implanted CV Devices

For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

Industry Payments to Vascular Neurologists Jump in the Thrombectomy Era

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

Community Death Rates Following Type 2 MI Speak to Lack of Treatments, Trials

The Biggest News of 2019: TCTMD’s Top 10

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content